Department of Surgery, Division of Trauma, Acute and Critical Care Surgery, Duke University School of Medicine, Durham, NC, USA.
Icahn School of Medicine at Mount Sinai, Department of Surgery, Mount Sinai Hospital, New York, NY, USA.
Eur J Trauma Emerg Surg. 2024 Jun;50(3):781-789. doi: 10.1007/s00068-023-02358-x. Epub 2023 Sep 29.
The inability to achieve primary fascial closure (PFC) after emergency laparotomy increases the rates of adverse outcomes including fistula formation, incisional hernia, and intraabdominal infection. Hypertonic saline (HTS) infusion improves early PFC rates and decreases time to PFC in patients undergoing damage control laparotomy (DCL) after injury. We hypothesized that in patients undergoing DCL after penetrating abdominal injury, HTS infusion would decrease the time to fascial closure as well as the volume of crystalloid required for resuscitation without inducing clinically relevant acute kidney injury (AKI) or electrolyte derangements.
We retrospectively analyzed all penetrating abdominal injury patients undergoing DCL within the University of Pennsylvania Health System (January 2015-December 2018). We compared patients who received 3% HTS at 30 mL/h (HTS) to those receiving isotonic fluid (ISO) for resuscitation while the abdominal fascia remained open. Primary outcomes were the rate of early PFC (PFC within 72 h) and time to PFC; secondary outcomes included acute kidney injury, sodium derangement, ventilator-free days, hospital length of stay (LOS), and ICU LOS. Intergroup comparisons occurred by ANOVA and Tukey's comparison, and student's t, and Fischer's exact tests, as appropriate. A Shapiro-Wilk test was performed to determine normality of distribution.
Fifty-seven patients underwent DCL after penetrating abdominal injury (ISO n = 41, HTS n = 16). There were no significant intergroup differences in baseline characteristics or injury severity score. Mean time to fascial closure was significantly shorter in HTS (36.37 h ± 14.21 vs 59.05 h ± 50.75, p = 0.02), and the PFC rate was significantly higher in HTS (100% vs 73%, p = 0.01). Mean 24-h fluid and 48-h fluid totals were significantly less in HTS versus ISO (24 h: 5.2L ± 1.7 vs 8.6L ± 2.2, p = 0.01; 48 h: 1.3L ± 1.1 vs 2.6L ± 2.2, p = 0.008). During the first 72 h, peak sodium (Na) concentration (146.2 mEq/L ± 2.94 vs 142.8 mEq/L ± 3.67, p = 0.0017) as well as change in Na from ICU admission (5.1 mEq/L vs 2.3, p = 0.016) were significantly higher in HTS compared to ISO. Patients in the HTS group received significantly more blood in the trauma bay compared to ISO. There were no intergroup differences in intraoperative blood transfusion volume, AKI incidence, change in chloride concentration (△Cl) from ICU admit, Na to Cl gradient (Na:Cl), initial serum creatinine (Cr), peak post-operative Cr, change in creatinine concentration (△Cr) from ICU admission, creatinine clearance (CrCl), initial serum potassium (K), peak ICU K, change in K from ICU admission, initial pH, highest or lowest post-operative pH, mean hospital LOS, ICU LOS, and ventilator-free days.
HTS infusion in patients undergoing DCL after penetrating abdominal injury decreases the time to fascial closure and led to 100% early PFC. HTS infusion also decreased resuscitative fluid volume without causing significant AKI or electrolyte derangement. HTS appears to offer a safe and effective fluid management approach in patients who sustain penetrating abdominal injury and DCL to support early PFC without inducing measurable harm.
Level III.
在急诊剖腹手术后无法实现初次筋膜闭合(PFC)会增加不良后果的发生率,包括瘘管形成、切口疝和腹腔感染。高渗盐水(HTS)输注可提高损伤控制性剖腹手术后患者的早期 PFC 率,并缩短达到 PFC 的时间。我们假设在穿透性腹部损伤后接受损伤控制性剖腹手术的患者中,HTS 输注可缩短筋膜闭合时间,并减少复苏所需的晶体液量,而不会引起临床相关的急性肾损伤(AKI)或电解质紊乱。
我们回顾性分析了宾夕法尼亚大学卫生系统(2015 年 1 月至 2018 年 12 月)内所有接受损伤控制性剖腹手术的穿透性腹部损伤患者。我们比较了接受 3% HTS 以 30ml/h 输注(HTS)和接受等渗液(ISO)复苏的患者,同时保持腹部筋膜开放。主要结局是早期 PFC(72 小时内 PFC)和达到 PFC 的时间;次要结局包括急性肾损伤、钠紊乱、无呼吸机天数、住院时间(LOS)和 ICU LOS。组间比较采用 ANOVA 和 Tukey 比较、学生 t 检验和 Fischer 确切检验,视情况而定。进行 Shapiro-Wilk 检验以确定分布的正态性。
57 例穿透性腹部损伤患者接受了损伤控制性剖腹手术(ISO 组 n=41,HTS 组 n=16)。两组患者的基线特征和损伤严重程度评分无显著差异。HTS 组达到筋膜闭合的时间明显缩短(36.37 小时±14.21 与 59.05 小时±50.75,p=0.02),HTS 组的 PFC 率明显更高(100% 与 73%,p=0.01)。HTS 与 ISO 相比,24 小时和 48 小时的液体总量明显减少(24 小时:5.2L±1.7 与 8.6L±2.2,p=0.01;48 小时:1.3L±1.1 与 2.6L±2.2,p=0.008)。在最初的 72 小时内,HTS 组的钠(Na)峰值浓度(146.2mEq/L±2.94 与 142.8mEq/L±3.67,p=0.0017)以及 ICU 入院时 Na 的变化(5.1mEq/L 与 2.3,p=0.016)明显高于 ISO 组。HTS 组患者在创伤区接受的血液量明显多于 ISO 组。两组术中输血量、AKI 发生率、ICU 入院时氯(Cl)浓度的变化、Na:Cl 梯度、初始血清肌酐(Cr)、术后最高 Cr、ICU 入院时 Cr 浓度的变化、肌酐清除率(CrCl)、初始血清钾(K)、ICU 最高 K、ICU 入院时 K 的变化、初始 pH 值、术后最高或最低 pH 值、平均住院 LOS、ICU LOS 和无呼吸机天数均无差异。
穿透性腹部损伤后行损伤控制性剖腹手术后,HTS 输注可缩短达到筋膜闭合的时间,并实现 100%的早期 PFC。HTS 输注还可减少复苏所需的液体量,而不会引起明显的 AKI 或电解质紊乱。HTS 似乎为穿透性腹部损伤和损伤控制性剖腹手术患者提供了一种安全有效的液体管理方法,可支持早期 PFC,而不会造成可测量的伤害。
III 级。